Om opens up early access for customers

Om invites early access customers to experience our innovative Data-Generation-as-a-Service (DaaS) platform, transforming medicine discovery through rapid, large-scale molecule screening. Our advanced platform efficiently screens approximately 350 million molecules against your protein of interest, leveraging synthetic biology, pico-scale droplet engineering, and next-generation sequencing to generate comprehensive, high-quality interaction datasets.

We offer two tailored pathways to meet your research needs: Standard Screening ($2,500 per protein sequence): Your protein is screened, and the resulting data contributes to our expanding public datasets, enhancing broader accessibility and collective scientific advancement. Private Screening ($5,000 per protein sequence): Your screening data remains confidential and exclusive to your team, providing a private, strategic advantage tailored specifically to your research goals. Both options provide immediate access to powerful insights through our Origin API, delivering predictive binding scores from 0 (non-binder) to 1 (highly likely binder).